Clinical trial
The Spiration Valve System for the Treatment of Severe Emphysema
NCT01989182 is registered in ClinicalTrials.gov with Olympus Corporation of the Americas as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Spiration Valve System for the Treatment of Severe Emphysema
- Lead sponsor
- Olympus Corporation of the Americas
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 8, 2013
- Completion date
- March 31, 2017
- Enrollment
- 107 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.
empyhsema, pulmonary disease, chronic obstructive